Seth Klarman: portfolio of Baupost Group

Seth Klarman leads the Baupost Group, which follows a value approach and looks for securities trading below their estimated worth.

Source: 13F filing with the US Securities and Exchange Commission dated May 14, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q1 2021. Go to the latest filing (Q3 2026)

12.5B USDQ1 2021
Total value of stock positions
12.5B USD
Positions
58
Share of the ten largest
65.0%

The ten largest positions Q1 2021

  1. Intel 11.9%▲ +28.2%
  2. Liberty Global PLC 11.1%unchanged
  3. eBay Inc. 9.0%▼ −41.1%
  4. Qorvo Inc 7.6%▲ +17.7%
  5. Viasat Inc 6.3%unchanged
  6. Alphabet Inc. (Class C) 4.8%▲ +265.6%
  7. Willis Towers Watson 4.6%new
  8. Micron Technology 3.8%▲ +3.9%
  9. Meta Platforms 3.0%▲ +41.0%
  10. PG&E Corporation 2.9%unchanged
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 12.7B USD).
Choose a quarter (54 filings)

All positions Q1 2021

Positions Q1 2021 per 13F filing, 4 of 4
Symbol Weight Shares Reported value Change Held since
EBAY eBay Inc. 9.0% 18,324,423 1.1B USD −41.1% reduced Q4 2018 10 quarters
FOXA Fox Corporation (Class A) 2.2% 7,610,818 274.8M USD −65.7% reduced Q1 2019 9 quarters
Fidelity National Financial 1.0% 3,036,935 123.5M USD −20.1% reduced Q4 2020 2 quarters
Atara Biotherapeutics Inc 1.0% 8,477,488 121.7M USD −6.9% reduced Q4 2014 26 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Plus 1 position in convertible bonds and bonds worth 30.6M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Theravance Biopharma Inc principal 30.0M USD 30.6M USD

Breakdown by sector

  • Technology 15.7%
  • Communication Services 11.6%
  • Consumer Discretionary 9.0%
  • Financials 4.6%
  • Utilities 2.9%
  • Materials 2.3%
  • Real Estate 1.3%
  • not in our coverage 52.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close